Privia Health Group (PRVA) Stock Forecast, Price & News

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last year. There are currently 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PRVA shares.
View PRVA analyst ratings or view top-rated stocks.

13 Wall Street research analysts have issued 1-year price objectives for Privia Health Group's shares. Their PRVA share price forecasts range from $28.00 to $51.00. On average, they predict the company's share price to reach $39.19 in the next year. This suggests a possible upside of 60.1% from the stock's current price.
View analysts price targets for PRVA or view top-rated stocks among Wall Street analysts.

Privia Health Group's stock was trading at $22.71 on January 1st, 2023. Since then, PRVA stock has increased by 7.8% and is now trading at $24.48.
View the best growth stocks for 2023 here.

Privia Health Group saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 5,740,000 shares, an increase of 189.9% from the April 30th total of 1,980,000 shares. Based on an average daily volume of 1,180,000 shares, the short-interest ratio is currently 4.9 days. Currently, 5.4% of the company's shares are short sold.
View Privia Health Group's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our PRVA earnings forecast.

Privia Health Group, Inc. (NASDAQ:PRVA) issued its earnings results on Tuesday, February, 28th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.17. The business had revenue of $364.42 million for the quarter, compared to the consensus estimate of $337.16 million. Privia Health Group had a trailing twelve-month return on equity of 3.20% and a net margin of 1.14%.

ETFs with the largest weight of Privia Health Group (NASDAQ:PRVA) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), ROBO Global Healthcare Technology and Innovation ETF (HTEC), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Franklin Genomic Advancements ETF (HELX), First Trust Mid Cap Growth AlphaDEX Fund (FNY), Renaissance IPO ETF (IPO), iShares U.S. Healthcare Providers ETF (IHF) and Principal U.S. Small-Cap Multi-Factor ETF (PSC).

Privia Health Group issued an update on its FY 2023 earnings guidance on Wednesday, April, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.55 billion-$1.65 billion, compared to the consensus revenue estimate of $2.79 billion.

(PRVA) raised $351 million in an initial public offering on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Privia Health Group trades on the NASDAQ under the ticker symbol "PRVA."

Privia Health Group's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (3.99%), Bank of New York Mellon Corp (3.09%), Principal Financial Group Inc. (1.99%), Riverbridge Partners LLC (1.96%), FMR LLC (1.47%) and Franklin Resources Inc. (1.09%). Insiders that own company stock include Advisors LLC Mbd, David Mountcastle, Jeffrey B Butler, Jeffrey Daniel Bernstein, Matthew Shawn Morris, Pamplona Capital Partners Iii,, Parth Mehrotra, Thomas Bartrum and William M Sullivan.
View institutional ownership trends.

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PRVA stock can currently be purchased for approximately $24.48.

Privia Health Group (NASDAQ:PRVA) has a market capitalization of $2.83 billion and generates $1.36 billion in revenue each year. The company earns $-8,590,000.00 in net income (profit) each year or $0.11 on an earnings per share basis.

The company employs 810 workers across the globe.

The official website for the company is www.priviahealth.com. The company can be reached via phone at 571-366-8850 or via email at ir@priviahealth.com.